Would you pay for a $600 scale that informs you of your risk of hypertension and cardiac efficiency? Withings is betting big that you will.
SAN FRANCISCO--(BUSINESS WIRE)--Bodyport, a digital therapeutics company on a mission to address complex chronic conditions, announced today that its noninvasive biomarker platform, the Bodyport ...
The Bodyport Cardiac Scale is designed to detect signals through an individual’s feet to noninvasively measure a broad spectrum of hemodynamic biomarkers for heart function and fluid status. The Food ...